Clinical Trial Update: Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression [NA]

View source ↗

Summary

A completed study investigated the brain dopaminergic effects of adding aripiprazole to treatment for treatment-resistant major depressive disorder, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Major Depressive Disorder | NA | Status: COMPLETED | Results posted: 2018-04-19